Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Apr 2, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Incyte Corp
| 403 |
$56.97 | $22,958.91 | +2.62% | 15.79K |
Mar 28
| |||||||
Incyte Corp
| 412 |
$62.79 | $25,869.48 | +2.75% | 15.38K |
Dec 29
| |||||||
Incyte Corp
| 379 |
$57.77 | $21,894.83 | +2.60% | 14.97K |
Sep 29
| |||||||
Incyte Corp
| 380 |
$62.25 | $23,655.00 | +2.67% | 14.59K |
Jun 30
| |||||||
Incyte Corp
| 2.5K |
—
|
—
| +21.40% | 14.21K |
Jun 14
| |||||||
Xilio Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 12
| |||||||
Exact Sciences Corp
| 3.6K |
—
|
—
| +32.42% | 14.7K |
Jun 8
| |||||||
Incyte Corp
| 318 |
$72.27 | $22,981.86 | +2.79% | 11.71K |
Mar 31
| |||||||
Incyte Corp
| 294 |
$80.32 | $23,614.08 | +2.65% | 11.39K |
Dec 30
|
Scheduled
| ||||||
Incyte Corp
| 339 |
$66.64 | $22,590.96 | +3.15% | 11.09K |
Sep 30
|
Scheduled
| ||||||
Incyte Corp
| 321 |
$75.97 | $24,386.37 | +3.08% | 10.76K |
Jun 30
|
Scheduled
| ||||||
Agios Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 21
| |||||||
Xilio Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 15
| |||||||
Incyte Corp
| 2.14K |
—
|
—
| +25.86% | 10.43K |
Jun 15
| |||||||
Exact Sciences Corp
| 5.61K |
—
|
—
| +102.00% | 11.1K |
Jun 9
| |||||||
Agios Pharmaceuticals, Inc.
| 1.58K |
—
|
—
| +31.93% | 6.55K |
May 20
| |||||||
Incyte Corp
| 326 |
$79.42 | $25,890.92 | +4.09% | 8.29K |
Mar 31
|
Scheduled
| ||||||
Incyte Corp
| 343 |
$73.40 | $25,176.20 | +4.50% | 7.96K |
Dec 31
|
Scheduled
| ||||||
Xilio Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Oct 26
| |||||||
Xilio Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Incyte Corp
| 321 |
$68.78 | $22,078.38 | +4.40% | 7.62K |
Sep 30
|
Scheduled
| ||||||
Exact Sciences Corp
| 2.57K |
—
|
—
| +87.64% | 5.5K |
Jun 30
| |||||||
Incyte Corp
| 283 |
$84.13 | $23,808.79 | +4.03% | 7.3K |
Jun 30
|
Scheduled
| ||||||
Agios Pharmaceuticals, Inc.
| 1.69K |
—
|
—
| +51.43% | 4.96K |
May 28
| |||||||
Incyte Corp
| 1.92K |
—
|
—
| +37.75% | 7.02K |
May 26
| |||||||
Agios Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 20
| |||||||
Incyte Corp
| 298 |
$81.27 | $24,218.46 | +6.21% | 5.09K |
Mar 31
|
Scheduled
| ||||||
Exact Sciences Corp
| 2.93K |
—
|
—
|
∞
| 2.93K |
Mar 18
| |||||||
Exact Sciences Corp
|
0
|
—
|
—
|
—
|
0
| ||||||||
Incyte Corp
| 281 |
$86.98 | $24,441.38 | +6.22% | 4.8K |
Dec 31
|
Scheduled
| ||||||
Incyte Corp
| 260 |
$89.74 | $23,332.40 | +6.11% | 4.51K |
Sep 30
|
Scheduled
| ||||||
Incyte Corp
| 229 |
$103.97 | $23,809.13 | +5.69% | 4.25K |
Jun 30
|
Scheduled
| ||||||
Agios Pharmaceuticals, Inc.
| 1.88K |
—
|
—
| +134.14% | 3.28K |
May 28 - May 29
| |||||||
Incyte Corp
| 1.28K |
—
|
—
| +46.72% | 4.03K |
May 26
| |||||||
Incyte Corp
| 287 |
$73.23 | $21,017.01 | +11.68% | 2.74K |
Mar 31
|
Scheduled
| ||||||
Incyte Corp
| 231 |
$87.32 | $20,170.92 | +10.38% | 2.46K |
Dec 31
|
Scheduled
| ||||||
Incyte Corp
| 266 |
$74.23 | $19,745.18 | +13.57% | 2.23K |
Sep 30
|
Scheduled
| ||||||
Alexion Pharmaceuticals, Inc.
| -5.23K |
$124.20 | -$649,566.00 | -5.47% | 90.45K | +1 |
Jul 11
| ||||||
Incyte Corp
| 237 |
$84.96 | $20,135.52 | +13.76% | 1.96K |
Jun 28
|
Scheduled
| ||||||
Agios Pharmaceuticals Inc
| 1.4K |
—
|
—
|
∞
| 1.4K |
May 29 - May 31
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.